AbbVie Inc

2026-09-16 19:26; UTC

AbbVie shares moved lower as traders monitor the stock's approach to a 52-week high, with $267.47 seen as a critical resistance level.

2026-09-15 23:01; UTC

AbbVie Inc. shares fell in after-hours trading, reflecting broader market negativity following a decline in the New York Empire State Manufacturing Index.

2026-09-14 21:56; UTC

Shares of AbbVie Inc. are trading higher in after-market hours, maintaining a position above the 20-day moving average and reflecting recent upward trends.

2026-09-11 20:08; UTC

AbbVie Inc. shares are higher following positive Phase 3 LUNA study results for atogepant and strong response rates for investigational BCMA×CD3 BiTE in multiple myeloma trials.

2026-09-10 23:41; UTC

AbbVie Inc declared a quarterly dividend of $1.73, with a record date of October 15, 2026. Shares are higher in after-hours trading.

2026-09-09 23:01; UTC

AbbVie Inc. shares advanced in after-market trading, recovering from earlier lows amid broader market dynamics and rising inflation concerns linked to geopolitical tensions.

2026-09-08 23:06; UTC

AbbVie Inc. shares are higher in after-market hours, following a pullback earlier in the session amid broader market expectations for a Federal Reserve rate hike.

2026-09-04 23:05; UTC

AbbVie Inc. shares are lower in after-market hours, reflecting cautious market sentiment amid mixed economic signals and a slight uptick in the unemployment rate.

2026-09-03 23:11; UTC

AbbVie Inc. shares are trading higher in after-market hours following positive results from the Phase 3 CERVINO study of etentamig for multiple myeloma.

2026-09-02 23:51; UTC

AbbVie Inc. shares are lower in after-market trading, despite remaining above the 20-day moving average, amid a weaker-than-expected ADP payrolls report.

2026-09-01 23:56; UTC

AbbVie Inc. has filed for a new Skyrizi regimen to treat Crohn's disease. Shares are lower in after-market hours amid broader market pressure from rising oil prices.

2026-08-31 23:01; UTC

AbbVie Inc shares are higher in after-market trading, reflecting positive momentum. No specific company news was identified to explain the price movement.

2026-08-28 20:08; UTC

AbbVie shares are lower as the company seeks European approval for SKYRIZI. Rising U.S. Treasury yields amid inflation concerns contribute to market declines.

2026-08-27 23:01; UTC

AbbVie Inc. seeks European approval for SKYRIZI to treat Crohn's disease. Shares are higher in after-hours trading following a recent dip.

2026-08-26 23:02; UTC

AbbVie Inc shares are trading lower in after-market hours, showing volatility after Wednesday's close with no specific news identified to explain the movement.

2026-08-25 20:07; UTC

AbbVie Inc shares are higher, supported by favorable macro conditions and lower Treasury yields. The stock is trading near the upper end of its one-month range.

2026-08-24 19:36; UTC

AbbVie Inc. shares are trading lower today, having reached a session low earlier. The stock remains above its 20-day moving average.

2026-08-21 20:06; UTC

AbbVie Inc is set to present new data on its bispecific antibody at the 2026 World Conference on Lung Cancer, boosting investor sentiment. Shares are higher today.

2026-08-20 19:31; UTC

AbbVie shares are lower today, despite Piper Sandler raising its price target to $303 from $298. The decline aligns with broader sector weakness.

2026-08-19 23:01; UTC

AbbVie Inc. is lower in after-market trading, driven by declines in the Biotechnology sub-sector. Recent sessions had shown upward momentum.

2026-08-18 23:51; UTC

Abbvie Inc shares are trading higher in after-market hours, reflecting resilience amid elevated bond yields and inflation concerns. The stock remains above its 20-day moving average.

2026-08-17 23:51; UTC

AbbVie Inc shares are trading lower in after-market hours amid weak broader market sentiment influenced by geopolitical tensions and rising crude oil prices.

2026-08-14 19:46; UTC

AbbVie Inc has begun a Phase 2 trial for ABBV-295, yet shares are lower amid negative market sentiment from a decline in U.S. retail sales.

2026-08-13 23:21; UTC

Abbvie Inc shares are lower in after-market hours, with no specific news identified for the decline. Initial jobless claims rose unexpectedly today.

2026-08-12 20:06; UTC

AbbVie Inc. shares are lower today, continuing a decline since Tuesday's close, despite FDA acceptance of a BOTOX Cosmetic application for jawline contouring.

2026-08-11 20:06; UTC

AbbVie shares are higher as BNP Paribas raises the price target to $247. Allergan Aesthetics enhances its Partner Privileges program to boost customer engagement.

2026-08-10 23:06; UTC

AbbVie Inc shares are lower in after-market hours amid mixed market sentiment influenced by geopolitical tensions and President Trump's comments on economic pressure.

2026-08-07 23:01; UTC

AbbVie Inc shares are trading lower in after-market hours, with no specific news identified to explain the decline. The stock remains near its one-month low.

2026-08-06 20:06; UTC

AbbVie Inc shares are lower as bearish sentiment grows in biotech and pharma sectors, with discussions highlighting potential resistance and negative momentum patterns.

2026-08-05 19:26; UTC

AbbVie shares are higher as Canada's Drug Agency recommends UBRELVY for migraine treatment. The company also raised its 2026 revenue outlook to $67.60 billion.